BENZONATATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Benzonatate, and when can generic versions of Benzonatate launch?
Benzonatate is a drug marketed by Acella, Ascent Pharms Inc, Bionpharma, Chartwell Rx, Cspc-nbp Pharm, Heritage Pharms Labs, Mikart, Nesher Pharms, Puracap Pharm Llc, Strides Pharma, Sun Pharm Inds Inc, Thepharmanetwork Llc, and Zydus Pharms Usa. and is included in thirteen NDAs.
The generic ingredient in BENZONATATE is benzonatate. There are six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the benzonatate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benzonatate
A generic version of BENZONATATE was approved as benzonatate by BIONPHARMA on January 29th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENZONATATE?
- What are the global sales for BENZONATATE?
- What is Average Wholesale Price for BENZONATATE?
Summary for BENZONATATE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 44 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Clinical Trials: | 4 |
| Patent Applications: | 2,335 |
| Drug Prices: | Drug price information for BENZONATATE |
| Drug Sales Revenues: | Drug sales revenues for BENZONATATE |
| What excipients (inactive ingredients) are in BENZONATATE? | BENZONATATE excipients list |
| DailyMed Link: | BENZONATATE at DailyMed |
See drug prices for BENZONATATE
Recent Clinical Trials for BENZONATATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 3 |
| Pfizer | Phase 1 |
Pharmacology for BENZONATATE
| Drug Class | Non-narcotic Antitussive |
| Physiological Effect | Decreased Tracheobronchial Stretch Receptor Activity |
Anatomical Therapeutic Chemical (ATC) Classes for BENZONATATE
US Patents and Regulatory Information for BENZONATATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thepharmanetwork Llc | BENZONATATE | benzonatate | CAPSULE;ORAL | 040627-002 | Jul 25, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms Usa | BENZONATATE | benzonatate | CAPSULE;ORAL | 040597-001 | Jun 8, 2007 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Acella | BENZONATATE | benzonatate | CAPSULE;ORAL | 091310-001 | Jan 16, 2015 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nesher Pharms | BENZONATATE | benzonatate | CAPSULE;ORAL | 040795-001 | Oct 31, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
